CVRdatabase
Menu

Reflab ApS

Private limited companyCVR 15322586HvidovreActive

Reflab ApS is a private limited company, based in Hvidovre, active in traditional, complementary and alternative treatments, founded in 1991. Equity was negative at the end of 2025 (−DKK 635k). The company went from a profit in 2024 to a loss of DKK 1.8m in 2025. Gross profit is higher than that of 78% of the companies in the industry in the database.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profitDKK 4.6m−22.6% vs. 2024
Net profit−DKK 1.8m−374.7% vs. 2024
Equity−DKK 635k−154.9% vs. 2024
Employees11latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit fell 23% (2024 → 2025), to DKK 4.6m.
  • Net profit went from a profit of DKK 653k to a loss of DKK 1.8m (2024 → 2025).
  • Equity turned negative: −DKK 635k (2024 → 2025).

Employees

  • 1 fewer employees than a year earlier: 11 (08/2026) against 12 (08/2025).

Management and owners, last 24 months

  • New in management: Gert Pynt Andersen (director, 01/06/2026) and Katrine Baumann Markussen (director, 12/06/2026).
  • Stepped down: Henrik Christensen (director, 01/06/2026).

Registrations, last 24 months

  • 01/01/2025: Industry changed to Traditional, complementary and alternative treatments (869600)

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 2m−DKK 1mDKK 0DKK 1mDKK 2m202020212022202320242025
EquityNet profit
Financial figures for Reflab ApS
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit1,8513,4353,2173,4565,9224,582−22.6%
Operating profit (EBIT)−1,145−433−745−1,1021,067−2,151−301.7%
Profit before tax−1,222−436−828−1,199837−2,298−374.6%
Net profit−888−341−646−936653−1,792−374.7%
Total assets6,2415,8235,1755,8116,3804,506−29.4%
Equity2,4282,0871,4405051,157−635−154.9%
Liabilities3,8133,7363,7185,2585,1185,091−0.5%
Cash and cash equivalents1429191,2476142,224529−76.2%
Average number of employees6777810+25%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 1mDKK 2mDKK 3mDKK 4mDKK 5mDKK 6m202020212022202320242025
Gross profitMedian, the industry (188 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Negative equity

    Equity was −DKK 635k at the end of 2025.

    How is this calculated?

    Equity in the latest annual report is below zero.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Reflab ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202520/04/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202423/06/2025The companyPDFXBRL
202301/01/2023 – 31/12/202325/03/2024The companyPDFXBRL
202201/01/2022 – 31/12/202224/03/2023The companyPDFXBRL
202101/01/2021 – 31/12/202125/04/2022The companyPDFXBRL
202001/01/2020 – 31/12/202017/03/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
0246810121409/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/2608/26
Employees

Position in the industry

188 companies in the database

Comparison with the other companies in traditional, complementary and alternative treatments based on the latest financial year.

Gross profitDKK 4.6mNo. 43 of 188
Better than 78% of the companies in the industry
Equity−DKK 635kNo. 183 of 188
Better than 3% of the companies in the industry
Number of employees11No. 16 of 188
Better than 92% of the companies in the industry

Industry median: gross profit DKK 2.5m, net profit DKK 154k, equity DKK 563k, 4 employees.

DKK 100kDKK 345kDKK 1.2mDKK 4.1mDKK 9.4mHere
Distribution of gross profit for 181 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 14,814of 69,742
Better than 79%
No. 66,260of 69,964
Better than 5%
Same industry and fewer than 20 employees181 companies in the comparison
No. 37of 181
Better than 80%
No. 176of 181
Better than 3%
Companies that are at least 30 years old10,276 companies in the comparison
No. 5,839of 10,152
Better than 42%
No. 10,032of 10,275
Better than 2%
All companies of type ApS66,508 companies in the comparison
No. 15,056of 66,379
Better than 77%
No. 62,735of 66,505
Better than 6%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Traditional, complementary and alternative treatments
Gross profit
  1. Reflab ApSDKK 4.6m
  2. Boel Akupunktur ApSDKK 14.2m
  3. Clearidium A/SDKK 12.3m
Net profit
  1. Reflab ApS−DKK 1.8m
  2. Boel Akupunktur ApSDKK 1.7m
  3. Clearidium A/SDKK 4.9m
Equity
  1. Reflab ApS−DKK 635k
  2. Boel Akupunktur ApSDKK 2.7m
  3. Clearidium A/SDKK 11.7m
Employees
  1. Reflab ApS11
  2. Boel Akupunktur ApS25
  3. Clearidium A/S14

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • R-Biopharm AG100%
Reflab ApS

Management

2 active registrations

Executive management

Executive management at Reflab ApS
NameRoleAppointed
Gert Pynt AndersenDirector01/06/2026
Katrine Baumann MarkussenDirector12/06/2026
Founders
Per Stahl Skov
Former management (9)
Former management at Reflab ApS
NameRoleAppointedResigned
Hendrik Kees Kam NolteBoard member22/04/199128/05/2003
Dorte Eldal RødsgaardBoard member22/04/199130/06/2000
Per Stahl SkovBoard member22/04/199121/07/2003
Per Stahl SkovDirector22/04/199114/12/2012
Eivind Frederik KrammeBoard member30/06/200028/05/2003
Eva Valbjørn SørensenBoard member21/07/200321/07/2003
Eva Valbjørn SørensenDirector21/07/200314/12/2012
Erik Dahl JensenDirector14/12/201227/09/2019
Henrik ChristensenDirector27/09/201901/06/2026

Signing rule: Selskabet tegnes af 2 direktører i forening eller af én direktør alene.

Address and production units

1 active production units

Kanalholmen 1
2650 Hvidovre

Hvidovre Municipality · Postcode 2650

Production units
Production unitAddressEmployeesP number
REFLAB ApSKanalholmen 1, 2, 2650 Hvidovre111000903041

Purpose

Selskabets formål er at drive laboratorievirksomhed ved udførelse af klinisk kemiske analyser, herunder produktion af diagnostiske kits til udførelse af nævnte analyser samt anden dermed i forbindelse stående virksomhed.

The purpose is quoted from the register in Danish.

Changes year by year

35 registered events
20264 changesmanagement 3 · accounts 1
  • Katrine Baumann Markussen appointed director
  • Gert Pynt Andersen appointed director
  • Henrik Christensen stepped down as director
  • Annual report for 2025 published
20252 changesaccounts 1 · industry 1
  • Annual report for 2024 published
  • Industry changed to Traditional, complementary and alternative treatments (869600)
20241 changeaccounts 1
  • Annual report for 2023 published
20232 changesaddress 1 · accounts 1
  • Moved to Kanalholmen 1, 2, 2650 Hvidovre
  • Annual report for 2022 published
20221 changeaccounts 1
  • Annual report for 2021 published
20211 changeaccounts 1
  • Annual report for 2020 published
20192 changesmanagement 2
  • Henrik Christensen appointed director
  • Erik Dahl Jensen stepped down as director
20171 changeaddress 1
  • Moved to Ole Maaløes Vej 3, 2200 København N
20141 changeaddress 1
  • Moved to Ole Maaløes Vej 3, 2200 København N
20123 changesmanagement 3
  • Erik Dahl Jensen appointed director
  • Eva Valbjørn Sørensen stepped down as director
  • Per Stahl Skov stepped down as director
20101 changeownership 1
  • R-Biopharm AG registered as owner (100%)
20081 changeindustry 1
  • Industry changed to Sundhedsvæsen i øvrigt i.a.n. (869090)
20037 changesmanagement 6 · name 1
  • Eva Valbjørn Sørensen appointed board member
  • Eva Valbjørn Sørensen stepped down as board member
  • Eva Valbjørn Sørensen appointed director
  • Per Stahl Skov stepped down as board member
  • Name changed from REFERENCELABORATORIET ApS to REFLAB ApS
  • Eivind Frederik Kramme stepped down as board member
  • Hendrik Kees Kam Nolte stepped down as board member
20002 changesmanagement 2
  • Eivind Frederik Kramme appointed board member
  • Dorte Eldal Rødsgaard stepped down as board member
19961 changecapital 1
  • Share capital changed from 80,000 DKK to 200,000 DKK
19915 changesfounded 1 · management 4
  • Registered as REFERENCELABORATORIET ApS
  • Dorte Eldal Rødsgaard appointed board member
  • Per Stahl Skov appointed director
  • Per Stahl Skov appointed board member
  • Hendrik Kees Kam Nolte appointed board member

Related companies

Same industry in Hvidovre

See all →

Same people in management

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.

View in CVRReport a correction